ACET
Price
$1.40
Change
-$0.00 (-0.00%)
Updated
Oct 10 closing price
26 days until earnings call
COLL
Price
$36.64
Change
-$0.00 (-0.00%)
Updated
Oct 10 closing price
26 days until earnings call
Ad is loading...

ACET vs COLL

Header iconACET vs COLL Comparison
Open Charts ACET vs COLLBanner chart's image
Adicet Bio
Price$1.40
Change-$0.00 (-0.00%)
Volume$253.7K
CapitalizationN/A
Collegium Pharmaceutical
Price$36.64
Change-$0.00 (-0.00%)
Volume$501.99K
CapitalizationN/A
View a ticker or compare two or three
ACET vs COLL Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
COLL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ACET vs. COLL commentary
Oct 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a StrongSell and COLL is a StrongBuy.

COMPARISON
Comparison
Oct 12, 2024
Stock price -- (ACET: $1.40 vs. COLL: $36.64)
Brand notoriety: ACET and COLL are both not notable
ACET represents the Biotechnology, while COLL is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 52% vs. COLL: 130%
Market capitalization -- ACET: $118.66M vs. COLL: $1.24B
ACET [@Biotechnology] is valued at $118.66M. COLL’s [@Pharmaceuticals: Other] market capitalization is $1.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileCOLL’s FA Score has 2 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • COLL’s FA Score: 2 green, 3 red.
According to our system of comparison, COLL is a better buy in the long-term than ACET.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 4 TA indicator(s) are bullish while COLL’s TA Score has 3 bullish TA indicator(s).

  • ACET’s TA Score: 4 bullish, 4 bearish.
  • COLL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ACET is a better buy in the short-term than COLL.

Price Growth

ACET (@Biotechnology) experienced а -1.41% price change this week, while COLL (@Pharmaceuticals: Other) price change was -8.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

ACET is expected to report earnings on Nov 06, 2024.

COLL is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COLL($1.24B) has a higher market cap than ACET($119M). COLL YTD gains are higher at: 19.038 vs. ACET (-25.926). COLL has higher annual earnings (EBITDA): 308M vs. ACET (-130.7M). COLL has more cash in the bank: 311M vs. ACET (224M). ACET has less debt than COLL: ACET (19.1M) vs COLL (674M). COLL has higher revenues than ACET: COLL (567M) vs ACET (0).
ACETCOLLACET / COLL
Capitalization119M1.24B10%
EBITDA-130.7M308M-42%
Gain YTD-25.92619.038-136%
P/E RatioN/A30.17-
Revenue0567M-
Total Cash224M311M72%
Total Debt19.1M674M3%
FUNDAMENTALS RATINGS
ACET vs COLL: Fundamental Ratings
ACET
COLL
OUTLOOK RATING
1..100
7278
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
10012
SMR RATING
1..100
9721
PRICE GROWTH RATING
1..100
6144
P/E GROWTH RATING
1..100
32100
SEASONALITY SCORE
1..100
n/a25

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (34) in the Medical Distributors industry is in the same range as COLL (65) in the Pharmaceuticals Other industry. This means that ACET’s stock grew similarly to COLL’s over the last 12 months.

COLL's Profit vs Risk Rating (12) in the Pharmaceuticals Other industry is significantly better than the same rating for ACET (100) in the Medical Distributors industry. This means that COLL’s stock grew significantly faster than ACET’s over the last 12 months.

COLL's SMR Rating (21) in the Pharmaceuticals Other industry is significantly better than the same rating for ACET (97) in the Medical Distributors industry. This means that COLL’s stock grew significantly faster than ACET’s over the last 12 months.

COLL's Price Growth Rating (44) in the Pharmaceuticals Other industry is in the same range as ACET (61) in the Medical Distributors industry. This means that COLL’s stock grew similarly to ACET’s over the last 12 months.

ACET's P/E Growth Rating (32) in the Medical Distributors industry is significantly better than the same rating for COLL (100) in the Pharmaceuticals Other industry. This means that ACET’s stock grew significantly faster than COLL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETCOLL
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
63%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
ACET
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
COLL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME20.910.41
+2.00%
GameStop Corp
SPY576.13-1.01
-0.18%
SPDR® S&P 500® ETF Trust
AAPL229.04-0.50
-0.22%
Apple
BTC.X60274.500000-307.601560
-0.51%
Bitcoin cryptocurrency
TSLA238.77-2.28
-0.95%
Tesla

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-1.41%
OGI - ACET
41%
Loosely correlated
-0.60%
DVAX - ACET
39%
Loosely correlated
-2.93%
CRON - ACET
36%
Loosely correlated
-0.47%
KYMR - ACET
36%
Loosely correlated
-0.23%
FATE - ACET
35%
Loosely correlated
-2.33%
More